Welcome to LookChem.com Sign In|Join Free
  • or
1H-Imidazole, 1-[2-[4-(phenylmethoxy)phenyl]ethyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

80199-93-5

Post Buying Request

80199-93-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

80199-93-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 80199-93-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,0,1,9 and 9 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 80199-93:
(7*8)+(6*0)+(5*1)+(4*9)+(3*9)+(2*9)+(1*3)=145
145 % 10 = 5
So 80199-93-5 is a valid CAS Registry Number.

80199-93-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[2-(4-phenylmethoxyphenyl)ethyl]imidazole

1.2 Other means of identification

Product number -
Other names 1H-Imidazole,1-[2-[4-(phenylmethoxy)phenyl]ethyl]

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:80199-93-5 SDS

80199-93-5Relevant academic research and scientific papers

Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis

Floresta, Giuseppe,Pittalà, Valeria,Sorrenti, Valeria,Romeo, Giuseppe,Salerno, Loredana,Rescifina, Antonio

, p. 334 - 339 (2018/10/05)

HO-1 inhibition is considered a valuable anticancer approach. In fact, up-regulation of HO-1 had been repeatedly reported in many types of human malignancies, and in these clinical cases, poor outcomes are reported. To identify novel HO-1 inhibitors suitable for drug development, a scaffold-hopping strategy calculation was utilized to design novel derivatives. Different parts of the selected molecule were analyzed and the different series of novel compounds were virtually evaluated. The calculation for the linker moiety of the classical HO-1 inhibitors structure led us to compounds 5 and 6. A synthetic pathway for the two molecules was designed and the compounds were synthesized. The biological activity revealed an HO-1 inhibition of 0.9 and 54 μM for molecules 5 and 6 respectively. This study suggested that our scaffold-hopping approach was successful and these results are ongoing for further development.

β1-Selective Adrenoceptor Antagonists. 3. 4-Azolyl-Linked Phenoxypropanolamines

Machin, Peter J.,Hurst, David N.,Bradshaw, Rachel M.,Blaber, Leslie C.,Burden, David T.,Melarange, Rosemary A.

, p. 503 - 509 (2007/10/02)

A series of 4-substituted phenoxypropanolamines has been prepared and examined for β-adrenoceptor activity.The 4-substituents, di- and triazole ring systems connected to the phenoxy ring by different length chains, were chosen as a means of introducing ca

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 80199-93-5